The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Albright Charles since 2018.
The trader's CIK number is 1682323.
At the time of the last reporting, Albright Charles was the EVP/Chief Scientific Officer of Editas Medicine, Inc.. (stock ticker symbol EDIT).
Also see all insider trading activities at Editas Medicine, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | EDIT | 0 | $0 | 72,788 | $2,988,708 | 77,977 | $990,600 |
| 2018 | EDIT | 0 | $0 | 20,000 | $709,799 | 20,000 | $330,200 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-12-15 | EDIT | Option Ex | 10,000 | 16.51 | 165,100 |
| 2020-12-15 | EDIT | Sale | 10,000 | 63.66 | 636,570 |
| 2020-12-09 | EDIT | Option Ex | 10,000 | 16.51 | 165,100 |
| 2020-12-09 | EDIT | Sale | 10,000 | 45.00 | 450,000 |
| 2020-12-07 | EDIT | Sale | 20,000 | 40.02 | 800,400 |
| 2020-12-07 | EDIT | Option Ex | 20,000 | 16.51 | 330,200 |
| 2020-11-09 | EDIT | Sale | 228 | 31.21 | 7,115 |
| 2020-10-15 | EDIT | Sale | 3,000 | 31.39 | 94,170 |
| 2020-08-17 | EDIT | Option Ex | 10,000 | 16.51 | 165,100 |
| 2020-08-17 | EDIT | Sale | 10,000 | 35.29 | 352,900 |
| 2020-08-06 | EDIT | Option Ex | 10,000 | 16.51 | 165,100 |
| 2020-08-06 | EDIT | Sale | 10,000 | 37.47 | 374,700 |
| 2020-08-07 | EDIT | Sale | 238 | 34.99 | 8,327 |
| 2020-07-15 | EDIT | Sale | 3,000 | 32.22 | 96,660 |
| 2020-05-06 | EDIT | Sale | 151 | 25.28 | 3,817 |
| 2020-02-07 | EDIT | Sale | 622 | 26.95 | 16,762 |
| 2020-02-03 | EDIT | Sale | 5,549 | 26.54 | 147,287 |
| 2020-01-31 | EDIT | Option Ex | 17,977 | .00 | 0 |
| 2018-06-13 | EDIT | Sale | 10,000 | 35.98 | 359,799 |
| 2018-06-13 | EDIT | Option Ex | 10,000 | 16.51 | 165,100 |
| 2018-05-23 | EDIT | Option Ex | 10,000 | 16.51 | 165,100 |
| 2018-05-23 | EDIT | Sale | 10,000 | 35.00 | 350,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Albright Charles (EVP/Chief Scientific Officer of Editas Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.